KOR

e-Article

OS10.6 Infigratinib (BGJ398) in patients with recurrent gliomas with fibroblast growth factor receptor (FGFR) alterations: a multicenter phase II study.
Document Type
Article
Source
Neuro-Oncology; 2019 Supplement, Vol. 21, piii21-iii22, 2p
Subject
Language
ISSN
15228517